Nucleotide Sequence Sharing between the Human Genome and Primers for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Detection

Abstract

This study shows that oligonucleotide sequences are shared between the human genome and primers that have been proposed/used for SARS-CoV-2 detection by polymerase chain reaction (PCR). The high level of sharing (namely, up to 19mer with a maximum number of gaps equal to 2) might bear implications for the diagnostic validity of SARS-CoV-2 detection by PCR.

Keywords

PCR primers / SARS-CoV-2 detection / false positives

Funding

None.

Conflict of Interest

None declared.

References

[1] Kanduc D.Rare human codons and HCMV translational regulation. J Mol Microbiol Biotechnol 2017; 27(04): 213-216

[2] Kanduc D.Human codon usage: the genetic basis of pathogen latency. Glob Med Genet 2021; 8(03): 109-115

[3] Keita AK, Koundouno FR, Faye M.et al.Resurgence of Ebola virus in 2021 in guinea suggests a new paradigm for outbreaks. Nature 2021; 597(7877): 539-543

[4] Dayama P, Sampath K.Dengue disease outbreak detection. Stud Health Technol Inform 2014; 205: 1105-1109

[5] Wu D, Wu T, Liu Q, Yang Z.The SARS-CoV-2 outbreak: what we know. Int J Infect Dis 2020; 94: 44-48

[6] Patriquin G, Davidson RJ, Hatchette TF.et al.Generation of false-positive SARS-CoV-2 antigen results with testing conditions outside manufacturer recommendations: a scientific approach to pandemic misinformation. Microbiol Spectr 2021; 9(02): e0068321

[7] Benoit J, Benoit SW, Lippi G, Henry BM.False negative RT-PCR or false positive serological testing in SARS-CoV-2 diagnostics? Navigating between Scylla and Charybdis to prevent misclassification bias in COVID-19 clinical investigations. Diagnosis (Berl) 2020; 7(04): 405-407

[8] Verna R, Alallon W, Murakami M.et al.Analytical performance of COVID-19 detection methods (RT-PCR): scientific and societal concerns. Life (Basel) 2021; 11(07): 660

[9] Corman VM, Landt O, Kaiser M.et al.Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25(03): 2000045

[10] Surkova E, Nikolayevskyy V, Drobniewski F.False-positive COVID-19 results: hidden problems and costs. Lancet Respir Med 2020; 8(12): 1167-1168

[11] Eurosurveillance Editorial Team.Response to retraction request and allegations of misconduct and scientific flaws. Euro Surveill 2021; 26(05): 2102041

[12] Kanduc D.From anti-severe acute respiratory syndrome coronavirus 2 immune response to cancer onset via molecular mimicry and cross-reactivity. Glob Med Genet 2021; 8(04): 176-182

[13] Kanduc D.Thromboses and hemostasis disorders associated with coronavirus disease 2019: the possible causal role of cross-reactivity and immunological imprinting. Glob Med Genet 2021; 8(04): 162-170

[14] Kanduc D.From anti-SARS-CoV-2 immune responses to COVID-19 via molecular mimicry. Antibodies (Basel) 2020; 9(03): 33

[15] Kanduc D.From anti-SARS-CoV-2 immune response to the cytokine storm via molecular mimicry. Antibodies (Basel) 2021; 10(04): 36

[16] Altschul SF, Madden TL, Schäffer AA.et al.Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25(17): 3389-3402

[17] Boratyn GM, Thierry-Mieg J, Thierry-Mieg D, Busby B, Madden TL.Magic-BLAST, an accurate RNA-seq aligner for long and short reads. BMC Bioinformatics 2019; 20(01): 405

[18] Gadkar VJ, Goldfarb DM, Young V.et al.Development and validation of a new triplex real-time quantitative reverse Transcriptase-PCR assay for the clinical detection of SARS-CoV-2. Mol Cell Probes 2021; 58: 101744

[19] Qasem A, Shaw AM, Elkamel E, Naser SA.Coronavirus disease 2019 (COVID-19) diagnostic tools: a focus on detection technologies and limitations. Curr Issues Mol Biol 2021; 43(02): 728-748

[20] Uniprot. Accessed November2021 at:

RIGHTS & PERMISSIONS

Global Medical Genetics